Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis [Phase 3]
A long-term extension study of apremilast in pediatric patients (6-17) with moderate to severe plaque psoriasis has completed in Phase 3.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants [Phase 1]
Phase 1 clinical trial comparing pharmacokinetics, safety, tolerability, and immunogenicity of CKD-704, a risankizumab biosimilar, with EU- …
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis [NA]
A completed clinical trial from Hospices Civils de Lyon investigated cutaneous microcirculation and nervous sensitivity in psoriasis.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis [Phase 1]
Phase 1 clinical trial update describing safety and pharmacokinetics evaluation of LPX-TI641 in adults with atopic dermatitis and psoriasis.…
-
EMA approval · 2025-12-18EMA Authorised: Cosentyx (secukinumab) — Novartis Europharm Limited
The EMA authorised Cosentyx (secukinumab) for psoriatic arthritis, psoriasis, and ankylosing spondylitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? [NA]
A clinical trial is recruiting to assess whether adding treadmill walking to diet restriction improves outcomes in women with psoriasis and …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating post-inflammatory pigment alteration after psoriasis treatment (PIPA) involving Dermavant; enrol…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study) [NA]
This clinical trial update reports on using transcutaneous electrical nerve stimulation (TENS) to reduce injection-site pain from biologic t…
-
FDA approval · 2025-12-16FDA Approved: BECLOMETHASONE DIPROPIONATE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's Beclomethasone Dipropionate as an original-application generic medication, a topical cortic…
-
EMA approval · 2025-12-15EMA Authorised: Remicade (infliximab) — Janssen Cilag International NV
The EMA has authorised Remicade (infliximab) for multiple inflammatory diseases under Janssen Cilag International NV as the marketing author…
-
EMA approval · 2025-12-11EMA Authorised: Hyrimoz (adalimumab) — Sandoz GmbH
EMA authorised Hyrimoz (adalimumab) by Sandoz GmbH as a biosimilar to Humira for multiple inflammatory diseases, including rheumatoid arthri…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis [NA]
A completed clinical trial evaluated the role of reverse transcriptase inhibitors in treating psoriasis.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Trial of Academic Detailing to Promote Prescribing of Biosimilars [NA]
This clinical trial update describes an academic detailing intervention intended to promote prescribing of biosimilars among clinicians trea…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment [Phase 1]
A Phase 1 pharmacokinetics study evaluating Hemay005 tablets in patients with renal impairment has completed, with psoriasis listed as the c…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage [Phase 1]
This is a Phase 1 pharmacokinetic study evaluating Hemay005 tablets in subjects with psoriasis to assess how liver damage affects drug expos…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets [Phase 1]
Phase 1 pharmacokinetic interaction study evaluating Hemay005 tablets with midazolam (midazolam maleate tablets) in psoriasis patients has b…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis [EARLY_Phase 1]
An early Phase 1 trial comparing oral methotrexate with tofacitinib for chronic plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults [Phase 2]
A Phase 2 pilot trial is evaluating the safety and effectiveness of oral roflumilast for adults with moderate-to-severe psoriasis; the study…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis [Phase 1]
A Phase 1 multiple ascending-dose study of XmAb®27564 in psoriasis and atopic dermatitis has been terminated.
-
EMA approval · 2025-12-01EMA Authorised: Benepali (etanercept) — Samsung Bioepis NL B.V.
The European Medicines Agency authorised Benepali (etanercept), a biosimilar to etanercept, for inflammatory conditions including rheumatoid…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
This clinical trial update reports real-world use of deucravacitinib for moderate-to-severe psoriasis in Italy, with ongoing recruitment.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers [Phase 1]
A Phase 1 pharmacokinetic, safety and immunogenicity study comparing the new process CMAB015 with Cosentyx in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis [Phase 2]
A Phase 2 study evaluating the effectiveness and safety of BMS-986322 in adults with moderate-to-severe psoriasis has completed. Results hav…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: MIcrovascular dysfuNction In Moderate-severe Psoriasis [Phase 4]
This Phase 4 clinical trial update reports results on microvascular dysfunction in adults with moderate-to-severe psoriasis and cardiovascul…